Nonbreast Second Malignancies After Treatment of Primary Breast Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 73, Issue 5, 2009, Pages 1489-1492

  Yadav, Budhi S ^a   Sharma, Suresh C ^a   Patel, Firuza D ^a   Ghoshal, Sushmita ^a   Kapoor, Rakesh ^a   Kumar, Rajinder ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Breast cancer; Chemotherapy; Radiotherapy; Second malignancy

Indexed keywords

CHEMOTHERAPY; RADIOTHERAPY; REGRESSION ANALYSIS;

AFTER TREATMENTS; BREAST CANCER; HEAD AND NECKS; HORMONAL THERAPIES; HORMONE THERAPIES; OVARIAN CANCERS; PROPORTIONAL HAZARDS; RADIATION THERAPIES; REGRESSION MODELS; RELATIVE RISKS; RISK FACTORS; SECOND MALIGNANCY;

RISK PERCEPTION;

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; TAMOXIFEN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RISK; CLINICAL FEATURE; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; DISEASE SEVERITY; ENDOMETRIUM CANCER; FAMILY HISTORY; FEMALE; FOLLOW UP; GYNECOLOGIC CANCER; HEAD AND NECK CANCER; HEMATOLOGIC MALIGNANCY; HIGH RISK POPULATION; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MASTECTOMY; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; OVARY CANCER; PATIENT ASSESSMENT; PRIMARY TUMOR; PRIORITY JOURNAL; SECOND CANCER; THYROID CANCER;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; OVARIAN NEOPLASMS; RADIOTHERAPY DOSAGE; REGRESSION ANALYSIS; RISK; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 62649112427     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.07.004     Document Type: Article

References (11)

1. Thompson W.D. Methodologic perspectives on the study of multiple primary cancers. Yale J Biol Med 59 (1986) 505-516
2. Obedian E., Fischer B., and Haffty G. Second malignancies after treatment of early-stage breast cancer: Lumpectomy and radiation therapy versus mastectomy. J Clin Oncol 18 (2000) 2406-2412
3. Ribiero G.G., Magee B., Swindell R., et al. The Christie Hospital Breast Conservation Trial: An update at 8 years from inception. Clin Oncol 5 (1993) 278-283
4. Galper S., Gelman R., Recht A., et al. Second nonbreast malignancies after conservative surgery and radiation therapy for early-stage breast cancer. Int J Radiat Oncol Biol Phys 52 (2002) 406-414
5. Horn-Ross P.L. Multiple primary cancers involving the breast. Epidemiol Rev 15 (1993) 169-176
6. Tanaka H., Tsukuma H., Koyama H., et al. Second primary cancers following breast cancer in the Japanese female population. Jpn J Cancer Res 92 (2001) 1-8
7. Lee Y.T. Additional malignant neoplasms in patients with breast carcinoma. J Surg Oncol 31 (1986) 199-203
8. Mellemkjaer L., Friis S., Olsen J.H., et al. Risk of second cancer among women with breast cancer. Int J Cancer 118 (2006) 2285-2292
9. Kurtz J.M., Amalric R., Brandone H., et al. Contralateral breast cancer and other second malignancies in patients treated by breast-conserving therapy with radiation. Int J Radiat Oncol Biol Phys 15 (1988) 277-284
10. Early Breast Cancer Trialists Collaborative Group. Tamoxifen for early breast cancer: An overview of randomized trials. Lancet 351 (1998) 1451-1467
11. Valagussa P., Moliterni A., Terenziani M., et al. Second malignancies following CMF-based adjuvant chemotherapy in resectable breast cancer. Ann Oncol 5 (1994) 803-808